Bacteria colonizing the gastrointestinal
tract generally
grow well
in biofilms. In recent years, probiotic biofilms have been considered
the most promising fourth-generation probiotics. However, the research
into the functions of probiotic biofilms is just starting. In this
study, Lactobacillus reuteri DSM 17938
biofilms formed on electrospun cellulose acetate nanofibrous scaffolds
were contrasted with planktonic cells. Pathogen inhibition analysis
of Escherichia coli, Staphylococcus aureus, and Listeria
monocytogenes suggested a significant distinction
between the planktonic and biofilm groups. In human fecal fermentation, L. reuteri remodeled the microbiota by decreasing
the relative abundances of Proteobacteria, Escherichia–Shigella, and Desulfovibrio and increasing the relative abundances of Phascolarctobacterium, Bacteroides, and Lactobacillus. Moreover, L. reuteri biofilms played
more positive roles in microbiota modulation and short-chain fatty
acid production than planktonic L. reuteri. These findings provide an understanding of the beneficial effects
of probiotic biofilms, laying a foundation for the application of
probiotic biofilms as a health promoter.